Clinical Research Utility of ELISpot in Oncology 2026
Tracking Antitumor T Cell Activity in Personalized Medicine In the current year of 2026, the use of cellular assays to monitor the effectiveness of cancer vaccines has reached a new level of sophistication. Oncologists are utilizing these tools to measure the magnitude and breadth of the T-cell response against specific tumor antigens. This information is critical for determining whether a...
0 Commenti 0 condivisioni 2 Views 0 Anteprima